DrugPatentWatch Database Preview
Unique Pharm Labs Company Profile
» See Plans and Pricing
What is the competitive landscape for UNIQUE PHARM LABS, and what generic and branded alternatives to UNIQUE PHARM LABS drugs are available?
UNIQUE PHARM LABS has seventeen approved drugs.
Summary for Unique Pharm Labs
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 14 |
| NDAs: | 17 |
Drugs and US Patents for Unique Pharm Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unique Pharm Labs | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 077829-004 | Aug 26, 2009 | OTC | No | No | Start Trial | Start Trial | |||||
| Unique Pharm Labs | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 205663-001 | Jun 5, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Unique Pharm Labs | ATENOLOL | atenolol | TABLET;ORAL | 077443-003 | Sep 13, 2006 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Unique Pharm Labs | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 204721-002 | Jan 24, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Unique Pharm Labs | ATENOLOL | atenolol | TABLET;ORAL | 077443-002 | Sep 13, 2006 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
